Loading viewer...
earnings
Format: PDF earnings
Henlius reports first-half 2022 financial and operational results, covering commercial operations, innovative biologics R&D progress, biosimilar development milestones, and manufacturing capacity expansion. The presentation details clinical and pre-clinical phase advancements in biopharmaceutical development.
annual_report
44 Pages
earnings
16 Pages
Redknee
Singtel Q3 FY2017 Financial Results Presentation
earningsearnings
21 Pages
Singapore Telecommunications Limited